The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo

被引:225
|
作者
Guevara, NV
Kim, HS
Antonova, EI
Chan, L [3 ]
机构
[1] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA
关键词
D O I
10.1038/6585
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor protein p53 is an essential molecule in cell proliferation and programmed cell death (apoptosis), and has been postulated to play a principal part in the development of atherosclerosis. We have examined the effect of p53 inactivation on atherogenesis in apoE-knockout mice, an animal model for atherosclerosis(1,2). We found that, compared with p53(+/+)/apoE(-/-) mice, p53(-/-)apoE(-/-) mice developed considerably accelerated aortic atherosclerosis in the presence of a similar serum cholesterol in response to a high-fat diet. Furthermore, the atherosclerotic lesions in p53(-/-)apoE(-/-) mice had a significant (similar to 280%) increase in cell proliferation rate and an insignificant (similar to 180%) increase in apoptosis compared with those in p53(+/+)/apoE(-/-) mice. Our observations indicate that the role of p53 in atherosclerotic lesion development might be associated with its function in cell replication control, and that p53-independent mechanisms can mediate the apoptotic response in atherosclerosis.
引用
收藏
页码:335 / 339
页数:5
相关论文
共 50 条
  • [21] EDD induces cell cycle arrest by increasing p53 levels
    Smits, Veronique A. J.
    CELL CYCLE, 2012, 11 (04) : 715 - 720
  • [22] Incidence of apoptosis, cell proliferation and P53 expression in renal cell carcinomas
    Tannapfel, A
    Hahn, HA
    Katalinic, A
    Fietkau, RJ
    Kuhn, R
    Wittekind, CW
    ANTICANCER RESEARCH, 1997, 17 (2A) : 1155 - 1162
  • [23] Pharmacological activation of the p53 pathway by nutlin-3 inhibits medulloblastoma cell proliferation in vitro and in vivo
    Kuenkele, Annette
    de Preter, Katleen
    Vandesompele, Jo
    Thor, Theresa
    Pajtler, Kristian
    Hartmann, Wolfgang
    Heukamp, Lukas
    Schramm, Alexander
    Eggert, Angelika
    Schulte, Johannes H.
    EUROPEAN JOURNAL OF PEDIATRICS, 2011, 170 (02) : 267 - 268
  • [24] Absence of p53 mutations in malignant mesotheliomas
    Mor, O
    Yaron, P
    Huszar, M
    Yellin, A
    Jakobivitz, O
    BrokSimoni, F
    Rechavi, G
    Reichert, N
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 16 (01) : 9 - 13
  • [25] Abnormal centrosome amplification in the absence of p53
    Fukasawa, K
    Choi, T
    Kuriyama, R
    Rulong, S
    VandeVoude, GF
    SCIENCE, 1996, 271 (5256) : 1744 - 1747
  • [26] Cell proliferation and p53 expression in pseudoepitheliomatous hyperplasia of oral paracoccidioidomycosis
    Kaminagakura, E.
    Bonan, P. R. F.
    Lopes, M. A.
    Almeida, O. P.
    MYCOSES, 2006, 49 (05) : 393 - 396
  • [27] Tumor suppression by p53 in the absence of atm
    Bailey, S. Lawrence
    Gurley, Kay E.
    Hoon-Kim, Kyung
    Kelly-Spratt, Karen S.
    Kemp, Christopher J.
    MOLECULAR CANCER RESEARCH, 2008, 6 (07) : 1185 - 1192
  • [28] The p53 Gene Family: Control of Cell Proliferation and Developmental Programs
    A. A. Morgunkova
    Biochemistry (Moscow), 2005, 70 : 955 - 971
  • [29] THE P53 TUMOR SUPPRESSOR PROTEIN, A MODULATOR OF CELL-PROLIFERATION
    ULLRICH, SJ
    ANDERSON, CW
    MERCER, WE
    APPELLA, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (22) : 15259 - 15262
  • [30] The effect of p53 gene expression on the inhibition of cell proliferation by paclitaxel
    Sakashita, Fumio
    Osada, Shinji
    Takemura, Masao
    Imai, Hisashi
    Tomita, Hiroyuki
    Nonaka, Kenichi
    Takahashi, Takao
    Seishima, Mitsuru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (03) : 379 - 385